Clinical trial
Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA…
NCT00273507 · Rigshospitalet, Denmark, Other · Terminated
Key facts
| NCT number | NCT00273507 |
|---|---|
| Title | Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3 |
| Official title | Neoadjuvant Chemotherapy in Resectable NSCLC Stages IB, IIA, IIB, and IIIA/T3 But Not IIIA/N2 |
| Lead sponsor | Rigshospitalet, Denmark, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Non-small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | Carboplatin and Paclitaxel |
| Enrollment | 270 |
| Start date | Jan 1, 1998 |
| Completion | Jan 1, 2006 |
| First posted | Jan 9, 2006 |
| Last update posted | Sep 18, 2009 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: